A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD
Clinical trial NCT02285205 · COMPLETED
Trial details
- NCT number
- NCT02285205
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-11-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.